Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
60,085,788
-
Share change
-
-4,063,304
-
Total reported value
-
$5,272,566,932
-
Put/Call ratio
-
78%
-
Price per share
-
$87.75
-
Number of holders
-
268
-
Value change
-
-$360,433,519
-
Number of buys
-
150
-
Number of sells
-
100
Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q4 2019
As of 31 Dec 2019,
BLUEBIRD BIO INC - COM (BLUE) was held by
268 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,085,788 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, FMR LLC, Capital World Investors, VANGUARD GROUP INC, SANDS CAPITAL MANAGEMENT, LLC, BlackRock Inc., VICTORY CAPITAL MANAGEMENT INC, PRICE T ROWE ASSOCIATES INC /MD/, and STATE STREET CORP.
This page lists
268
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.